Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These medications have been life-changing for people struggling with obesity and type 2 diabetes, offering effective weight loss and better metabolic control
Springer Netherlands, pp 261315
Download the infographic to see key report statistics, including: 92% of plans cover GLP-1s for type 2 diabetes, while 36% cover GLP-1s for obesity 70% of respondents are moderately or very concerned about off-label use of GLP-1s for type 2 diabetes Among plans that cover GLP-1s for obesity, 81% use prior authorization and 58% have a BMI requirement The most commonly selected top reasons for excluding GLP-1s for obesity from coverage are that the drugs are too expensive to cover for all members for whom they would be prescribed (38%) and considering these to be lifestyle drugs which are excluded from coverage (27%)
We take the hassle out of the process by accepting insurance and managing prior authorizations, so you can prioritize your health without the burden of paperwork
Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barretts and oesophageal carcinoma: association or causality
US$ 21.42
US$ 27.03
US$ 21.62
US$ 24.31
US$ 26.40
US$ 23.89
